Nachrichten zur Terns Pharmaceuticals Inc. Aktie

Terns Pharmaceuticals ist ein biopharmazeutisches Unternehmen in der klinischen Entwicklungsphase. Nach dem Ausstieg aus der eigenen Adipositas-Entwicklung liegt die…

…

…

Terns Pharmaceuticals stock soars after positive Phase 1 CML drug data…

Auf der Liste der Top-10 Kursziele der Analysten fällt momentan u.a. eine Terns Pharmaceuticals (TERN) positiv auf. Der Biotechnologiekonzern hat…

…

Terns Pharmaceuticals (TERN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with…

Last year, Viking Therapeutics, a mid-cap biotech, made waves after it reported excellent phase 2 results for an investigational medicine…

Accomplished biotechnology CEO brings 25 years of strategic, operational, and legal experience Accomplished biotechnology CEO brings 25 years of strategic,…

…

…

Terns Pharmaceuticals just proved that its competitive in the weight loss field.…

FOSTER CITY, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN),…

Terns Pharmaceuticals and Summit Therapeutics are in the spotlight following positive updates on key candidates.…

FOSTER CITY, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN),…

…

Terns Pharmaceuticals, Inc. (TERN) outperforms the industry year to date on encouraging pipeline progress of its oncology candidate.…

FOSTER CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN),…